Baxter International Inc. (NYSE:BAX - Free Report) - Equities research analysts at Zacks Research lowered their Q4 2026 EPS estimates for shares of Baxter International in a report released on Thursday, November 19th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings per share of $0.59 for the quarter, down from their prior forecast of $0.60. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Baxter International's current full-year earnings is $2.10 per share. Zacks Research also issued estimates for Baxter International's Q1 2028 earnings at $0.44 EPS.
BAX has been the topic of a number of other reports. Barclays lifted their price target on shares of Baxter International from $20.00 to $23.00 and gave the stock an "underweight" rating in a research report on Monday, November 9th. UBS Group upped their price objective on shares of Baxter International from $19.00 to $25.00 and gave the company a "hold" rating in a research report on Tuesday, July 28th. Weiss Ratings raised Baxter International from a "sell (d-)" rating to a "sell (d)" rating in a research note on Friday, October 30th. JPMorgan Chase & Co. dropped their price objective on Baxter International from $26.00 to $25.00 and set a "neutral" rating on the stock in a research note on Friday, October 30th. Finally, Wall Street Zen upgraded Baxter International from a "hold" rating to a "buy" rating in a report on Saturday, October 31st. One research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Reduce" and a consensus target price of $23.27.
Read Our Latest Stock Analysis on Baxter International
Baxter International Stock Down 3.0%
Shares of NYSE:BAX opened at $25.38 on Friday. The company has a 50 day moving average price of $24.61 and a two-hundred day moving average price of $21.79. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.19 and a current ratio of 1.79. The company has a market capitalization of $13.13 billion, a PE ratio of -18.00, a PEG ratio of 3.84 and a beta of 0.68. Baxter International has a 52 week low of $15.73 and a 52 week high of $30.00.
Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.06. The business had revenue of $2.98 billion for the quarter, compared to analyst estimates of $2.91 billion. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.23%. Baxter International's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.69 EPS.
Baxter International Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International's payout ratio is presently -2.84%.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Innovator Capital Management LLC acquired a new position in Baxter International in the 3rd quarter worth $688,000. Coastal Bridge Advisors LLC bought a new position in Baxter International during the 3rd quarter worth about $416,000. New York State Common Retirement Fund increased its holdings in Baxter International by 3.7% during the 3rd quarter. New York State Common Retirement Fund now owns 236,074 shares of the medical instruments supplier's stock worth $5,666,000 after purchasing an additional 8,500 shares in the last quarter. Allworth Financial LP raised its stake in shares of Baxter International by 321.8% in the 3rd quarter. Allworth Financial LP now owns 24,340 shares of the medical instruments supplier's stock valued at $584,000 after purchasing an additional 18,569 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new stake in shares of Baxter International in the 3rd quarter valued at about $263,000. Institutional investors and hedge funds own 90.19% of the company's stock.
About Baxter International
(
Get Free Report)
Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Baxter International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baxter International wasn't on the list.
While Baxter International currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.